Please assess the completion status of the following clinical trial:

Trial Title: Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Males or female patients ≥ 55 years of age~* LVH as confirmed by echocardiogram~* Patients with high risk hypertension, currently treated or already taking antihypertensive medication~Exclusion Criteria:~* Renal artery stenosis~* Symptomatic heart failure or known ejection fraction \< 40%~* Myocardial infarction or stroke within 6 months~* Presence of cranial aneurysm clips, coronary artery metal stents and pacemakers~* Pregnant or lactating females~* Cancer within the last 5 years

- Gender: ALL
- Minimum Age: 55 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).